Oncology Institute Raises 2026 Revenue and Gross Profit Guidance
Oncology Institute reported Q2 revenue of approximately $161 million, up 35% year over year, and positive adjusted EBITDA. It raised full-year revenue guidance to $650–670 million and gross profit guidance to $105–110 million.